在心力衰竭和COPD中与PRRs相关的基因和免疫格局
Heqing Yang1, Tingting Mei2,3
1Second Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, People's Republic of China.
七个与模式识别受体相关的差异表达基因 (PRDEG) 被确定为心力衰竭 (HF) 和慢性阻塞性肺病 (COPD) 的关键生物标志物,突出了它们在诊断和基于免疫的治疗中的潜力.
科学领域:
- 生物医学研究的研究.
- 基因组学就是基因组学.
- 免疫学 免疫学 免疫学
背景情况:
- 心力衰竭 (HF) 和慢性阻塞性肺病 (COPD) 是导致住院和死亡的主要原因.
- 与模式识别受体相关的差异表达基因 (PRDEGs) 涉及疾病进展,免疫反应和组织重塑.
研究的目的:
- 为了确定关键的PRDEG和相关途径在HF和COPD.
- 探索免疫细胞透在这些疾病中的作用.
- 评估PRDEGs作为潜在的诊断和治疗生物标志物.
主要方法:
- 对四个基因表达综合 (GEO) 数据集 (GSE57338,GSE16499,GSE76925,GSE57148) 的分析.
- 不同基因表达分析,功能丰富分析和免疫透分析.
- 使用独立数据集进行验证.
主要成果:
- 七种PRDEGs (PTX3,UCHL1,IL1R1,PLA2G2A,CXCL12,SPP1,CD24) 在HF和COPD中显示出显著的差异性表达.
- 丰富分析将这些基因与细胞外流,白细胞迁移和NF-kappa B信号通路联系起来.
- 在HF和COPD样本之间观察到免疫细胞丰度的显著差异,涉及9种免疫细胞类型.
结论:
- 确定了7种PRDEG作为HF和COPD的潜在生物标志物.
- 突出了特定免疫细胞和信号通路在疾病发病过程中的参与.
- 建议免疫调节作为HF和COPD的潜在治疗策略.
更多相关视频
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
07:25Isolation of Macrophage Subsets and Stromal Cells from Human and Mouse Myocardial Specimens
Published on: December 17, 2019
相关概念视频
Heart Failure II: Pathophysiology
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Pathophysiology of Heart Failure
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
